Role of Positron Emission Tomography/Computed Tomography in Breast Cancer
作者： Austin C. Bourgeois , Lance A. Warren , Ted T. Chang , Scott Embry , Kathleen Hudson
DOI: 10.1016/J.RCL.2013.06.003
关键词:
摘要: Although positron emission tomography (PET) imaging may not be used in the diagnosis of breast cancer, use PET/computed is imperative all aspects cancer staging, treatment, and follow-up. PET will continue to relevant personalized medicine because accurate tumor status even more critical during after transition from a generic metabolic agent receptor imaging. Positron mammography an proposition that have benefits lower doses, but its limited without new radiopharmaceuticals.
elsevier.com
sci-hub.se 参考文章(84)
Laurence Champion, Etienne Brain, Anne-Laure Giraudet, Elise Le Stanc, Myriam Wartski, Véronique Edeline, Olivier Madar, Dominique Bellet, Alain Pecking, Jean-Louis Alberini, Breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management. Cancer. ,vol. 117, pp. 1621- 1629 ,(2011) , 10.1002/CNCR.25727
Raymond R Raylman, Jame Abraham, Hannah Hazard, Courtney Koren, Shannon Filburn, Judith S Schreiman, Sobha Kurian, Stan Majewski, Gary D Marano, Initial clinical test of a breast‐PET scanner Journal of Medical Imaging and Radiation Oncology. ,vol. 55, pp. 58- 64 ,(2011) , 10.1111/J.1754-9485.2010.02230.X
S. Michelle Shiller, Robert Weir, John Pippen, Metin Punar, Daniel Savino, The sensitivity and specificity of sentinel lymph node biopsy for breast cancer at Baylor University Medical Center at Dallas: a retrospective review of 488 cases. Proceedings (Baylor University. Medical Center). ,vol. 24, pp. 81- 85 ,(2011) , 10.1080/08998280.2011.11928687
François-Clément Bidard, David Hajage, Thomas Bachelot, Suzette Delaloge, Etienne Brain, Mario Campone, Paul Cottu, Philippe Beuzeboc, Emilie Rolland, Claire Mathiot, Jean-Yves Pierga, Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study. Breast Cancer Research. ,vol. 14, pp. 1- 10 ,(2012) , 10.1186/BCR3114
Robert Lisbona, Christopher J. Thompson, Marianne Aznar, Kavita Murthy, Antoine Loutfi, Jean H. Gagnon, Results of Preliminary Clinical Trials of the Positron Emission Mammography System PEM-I: A Dedicated Breast Imaging System Producing Glucose Metabolic Images Using FDG The Journal of Nuclear Medicine. ,vol. 41, pp. 1851- 1858 ,(2000)
Giles W. L. Boland, Michael A. Blake, Nagaraj S. Holalkere, Peter F. Hahn, PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. American Journal of Roentgenology. ,vol. 192, pp. 956- 962 ,(2009) , 10.2214/AJR.08.1431
Bas B. Koolen, Erik Vegt, Emiel J. Th. Rutgers, Wouter V. Vogel, Marcel P. M. Stokkel, Cornelis A. Hoefnagel, Annemarie Fioole-Bruining, Marie-Jeanne T. F. D. Vrancken Peeters, Renato A. Valdés Olmos, FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series Annals of Nuclear Medicine. ,vol. 26, pp. 86- 91 ,(2012) , 10.1007/S12149-011-0538-3
KL Cooper, Y Meng, S Harnan, SE Ward, P Fitzgerald, D Papaioannou, L Wyld, C Ingram, ID Wilkinson, E Lorenz, Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation Health Technology Assessment. ,vol. 15, ,(2011) , 10.3310/HTA15040
Eun Young Chae, Joo Hee Cha, Hak Hee Kim, Hee Jung Shin, Hyun Ji Kim, Ha Yeun Oh, Young Hwan Koh, Dae Hyuk Moon, Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis. Acta Radiologica. ,vol. 53, pp. 530- 535 ,(2012) , 10.1258/AR.2012.120015
Luis Gorospe, Subha Raman, Jon Echeveste, Norbert Avril, Yolanda Herrero, Susana Herna??ndez, Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nuclear Medicine Communications. ,vol. 26, pp. 671- 687 ,(2005) , 10.1097/01.MNM.0000171779.65284.EB